JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 28 No. 10 1521-1530
© 1987 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Specker, B. L.
Right arrow Articles by McDevitt, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Specker, B. L.
Right arrow Articles by McDevitt, R. A.

Pulmonary Embolism and Lung Scanning: Cost-Effectiveness and Benefit:Risk

Bonny L. Specker, Eugene L. Saenger, C. Ralph Buncher and Ruth A. McDevitt

Department of Pediatrics, Radioisotope Laboratory, Department of Radiology, Department of Biostatistics and Epidemiology, University of Cincinnati, Cincinnati, Ohio

Correspondence: For reprints contact: Eugene L. Saenger, MD, E.L. Saenger Radioisotope Laboratory—Mail Location #577, Dept. of Radiology, University of Cincinnati Hospital, Cincinnati, OH 45267.

ABSTRACT

The cost-effectiveness of pulmonary imaging (lung scan) on the management of 2,023 patients was studied. Prior and postscan probabilities of pulmonary embolism (PE) were obtained from referring physicians. After the scan, anticoagulant therapy (ACT) was appropriately changed in 20% of the patients and confirmed in 67%. The incremental cost of scanning was $124 per patient when the prior probability was 0.01–9.99%, dropping to $38 when the probability was 10–25%. Hospitalization and ACT cost was reduced when the prior probability was 25.01–99.99%. The greatest benefit in lives saved was when the prior probability was 25–74.99%; 1.5% of this probability group would survive as a result of the change in management attributable to the scan, at a cost of $117 per life saved. The benefit:risk ratio, as measured by lives saved compared to estimates of lives lost due to radiation exposure, was of the order of 6,000:1.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1987 by the Society of Nuclear Medicine.